EBX-102

Imperial College London · Phase 2 active Small molecule

At a glance

Generic name	EBX-102
Also known as	IMT capsules
Sponsor	Imperial College London
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EBX-102 CI brief — competitive landscape report
EBX-102 updates RSS · CI watch RSS
Imperial College London portfolio CI